Matches in Nanopublications for { ?s ?p "[Inactivation of RUNX3 was observed in 70% of the adenocarcinoma samples, and this was associated with promoter hypermethylation but not biased to EGFR/KRAS mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_assertion description "[Inactivation of RUNX3 was observed in 70% of the adenocarcinoma samples, and this was associated with promoter hypermethylation but not biased to EGFR/KRAS mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_provenance.
- NP992667.RApqrLSmlkhdtez7onlXsmgKkZB7CXbu07KsF2eyFlvME130_assertion description "[Inactivation of RUNX3 was observed in 70% of the adenocarcinoma samples, and this was associated with promoter hypermethylation but not biased to EGFR/KRAS mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992667.RApqrLSmlkhdtez7onlXsmgKkZB7CXbu07KsF2eyFlvME130_provenance.
- NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_assertion description "[Inactivation of RUNX3 was observed in 70% of the adenocarcinoma samples, and this was associated with promoter hypermethylation but not biased to EGFR/KRAS mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_provenance.